Celltrion to conduct clinical trials for Remsima in the U.S.
It will take about six months to receive the U.S. FDA’s approval for the clinical test, the company said.
Remsima is a bio...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
